T raumaTic brain injury (TBI) is a leading cause of death and morbidity in the United States.
lowing 3 criteria: age > 40 years, motor posturing, and systolic blood pressure < 90 mm Hg. 2 Various devices have been used for monitoring ICP, most commonly an intraventricular device (IVD) or an intraparenchymal device (IPD). These 2 types of devices require different insertion techniques and have different therapeutic capabilities. Despite the widespread use of these monitors, very few studies have investigated the effect of device type on outcome. Our purpose in the present study was to compare outcomes between these 2 types of ICP monitoring devices in patients with isolated severe blunt head trauma.
Methods
The institutional review board of the University of Southern California approved this study.
This retrospective observational study was based on the Trauma Quality Improvement Program (TQIP) database, an American College of Surgeons detailed trauma database with strict control over the quality of data entered by participating trauma centers. In the database, we searched for all patients with isolated, severe, blunt TBI who had an ICP monitor placed during a 2-year period (from 2013 to 2014) and included them in the study. Isolated severe TBI was defined as head trauma with an Abbreviated Injury Scale (AIS) score ≥ 3 and no other extracranial trauma with an AIS score ≥ 3. Patients transferred from outside hospitals and those who died upon arrival were excluded from the study.
Extracted variables included demographics, comorbidities, mechanisms of injury, head injury specifics (epidural, subdural, subarachnoid, intracranial hemorrhage, and diffuse axonal injury), AIS score for each body area, Injury Severity Score (ISS), vital signs in the emergency department, and craniectomy. Outcomes included in-hospital mortality, complications, number of ventilation days, intensive care unit (ICU) and hospital lengths of stay, and functional independence at discharge.
The study population was divided into 2 groups based on type of ICP monitoring device: IVD and IPD. Other types of devices, such as epidural and subdural types, were excluded because of their infrequent use.
Statistical Analysis
Categorical variables were reported as percentages, whereas continuous variables were reported as medians with interquartile ranges. Continuous variables were also dichotomized using clinically relevant cutoff points. Univariate analysis was used to compare differences between groups (death vs no death and 2 types of ICP monitoring). The Mann-Whitney U-test was used to compare medians for continuous data points, while the Fisher exact test or Pearson chi-square test was used to compare proportions for categorical variables.
Risk factor variables with a p < 0.2 on univariate analysis were included in a forward stepwise logistic regression to identify independent predictors of overall mortality and complications. A multicollinearity test was performed to identify correlations between variables. The accuracy of the test is calculated using the area under the curve with a 95% confidence interval. Variables with a p value < 0.05 were considered significant. All statistical analysis was performed using IBM SPSS for Windows version 23.0 (IBM Corp.). Among the 2562 patients with ICP monitoring, 1358 (53%) had an IVD placed and 1204 (47%) had an IPD inserted. The severity of the head AIS score did not affect the type of ICP monitoring device selected ( Table  2) . Overall, patients with an IVD were significantly more likely to have an age ≥ 65 years (p < 0.001) and a comorbid condition (55.0% vs 44.4%, p < 0.001) than the patients with an IPD, who in turn were significantly more likely to have an admission GCS score < 9 (65.0% vs 54.2%, p < 0.001; Table 1 ). The need for craniectomy was similar in the 2 groups (IPD 31.1% vs IVD 31.4%). There was no difference in the median ISS, ISS > 15, or head AIS Score 3, 4, or 5 between the 2 study groups.
Results

During
Overall in-hospital mortality was 28% (Table 3 ). The unadjusted 30-day mortality was significantly higher in the group with IVDs (29% vs 25.5%, p = 0.046). In the patients who survived, there was no significant difference between the 2 groups with regard to hospital stay, ICU stay, and number of ventilation days. However, there was a significantly higher incidence of systemic complications in the IPD group (40.2% vs 34.4%, p = 0.003). Functional outcome at discharge was similar in the 2 groups.
In the subgroup of patients with a head AIS Score 3 (80 patients), there was no significant difference in 30-day mortality between those with an IVD and those with an IPD (13.9% vs 6.8%, p = 0.457). The 30-day mortality in the 923 patients with a head AIS Score 4 was 15.2% versus 12.9% (p = 0.334) and in the 1559 patients with head AIS Score 5 was 37.4% versus 34.6% (p = 0.239), respectively. Forward stepwise logistic regression analysis identified age ≥ 65 years, head AIS Score 5, GCS score < 9, and fall as the injury mechanism as independent factors associated with increased mortality. Venous thromboembolism (VTE) prophylaxis was found to be an independent factor associated with reduced mortality. Craniectomy within 24 hours of admission and ICP monitoring with an IVD were not independent risk factors for mortality (Table 4 ). Forward stepwise logistic regression analysis identified age ≥ 65 years, head AIS Scores 4 and 5, and GCS score < 9 as independent factors associated with increased systemic complications. The type of ICP monitor was not an independent risk factor.
Discussion
Intracranial pressure monitoring has become the standard of care in the management of severe head trauma in both children and adults and is recommended in the Brain Trauma Foundation guidelines. 2 The established relationship between increased ICP and poor outcomes following head trauma has led to the widespread use of 20 mm Hg as the threshold for therapeutic interventions. For many decades, IVDs have been used as the only method of measuring ICP. More recently, IPDs have gained widespread popularity. In the present study, 53% of the ICP devices were intraventricular and 47% were intraparenchymal. The severity of head trauma did not influence the decision about the type of device to use.
Each method has its advantages and disadvantages. Advantages of the IVDs include the ability to recalibrate if needed, their potential therapeutic application in draining cerebrospinal fluid to reduce the ICP, and their low cost. A significant disadvantage is the need for accurate placement in the ventricle, which can be technically difficult, especially in patients with severe intracranial hypertension and compressed ventricles. In addition, there is an increased risk of intracerebral bleeding and infection. The IPDs are easy to insert because they can be located anywhere in the brain parenchyma. Moreover, the risk of bleeding or infection is lower than that with IVDs. However, these devices cannot be recalibrated, cannot drain cerebrospinal fluid for therapeutic purposes, and are expensive. Because of their inability to drain cerebrospinal fluid in cases with intracranial hypertension, other therapeutic interventionssuch as heavier sedation and analgesia, pharmacological paralysis, administration of mannitol or hypertonic saline, hyperventilation, or barbiturate coma-may be used. The effect of particular methods of lowering ICP on outcomes is not known.
Despite the widespread use of these 2 different types of devices, very little research has been done to assess the effect of the type of ICP monitoring on outcomes. In a retrospective review of 377 adult TBI patients requiring ICP monitoring, Kasotakis et al. reported no difference in mortality (IPD 30.9% vs IVD 32.2%, p = 0.82), functional outcome, or hospital stay. 6 However, there was a higher incidence of device-related complications (11.9% vs 31.1%, p < 0.001), longer duration of ICP monitoring, and longer ICU length of stay in the IVD group. In a more recent prospective observational study of 122 patients requiring ICP monitoring, Liu et al. reported that those managed with IVD had significantly better 6-month survival than those managed with IPD (88.7% vs 68.3%, p = 0.006). 8 There was no statistically significant difference between the groups in device-related complications (p = 0.448). These authors concluded that IVDs are superior to the IPDs. In a commentary, Valadka suggested that on the basis of existing data, large, high-quality randomized studies are needed. 13 In the current study we identified some potentially important findings. First, compliance with the Brain Trauma Foundation guidelines for ICP monitoring is very low. In the group of 13,188 patients with severe head trauma and a GCS score < 9, which met the Brain Trauma Foundation guidelines for ICP monitoring, only 11.5% had an ICP monitoring device inserted. Low compliance with the Brain Trauma Foundation guidelines for ICP monitoring has been reported in other studies as well. 11 The effect of guideline compliance on outcomes is outside the scope of the present study. Nonetheless, other studies have reported improved outcomes with guideline compliance.
11 However, several authors have challenged these findings, reporting no benefit or even worse outcomes in the setting of monitor placement. A recent randomized study reported that treating patients with severe head trauma based on imaging and clinical examination was as good as directed therapy based on intraparenchymal pressure monitoring. 3 In a retrospective analysis Cremer et al. concluded that patients managed with ICP monitors had prolonged mechanical ventilation and increased levels of therapy intensity, without evidence of improved outcomes. 4 In a Na- ma Foundation guidelines was associated with worsening survival and warned against the use of ICP monitoring as a quality benchmark.
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A second important finding from the study was that the type of ICP monitoring device does not seem to have any effect on outcome. Although on univariate analysis there was a higher 30-day mortality with IVDs (29% vs 25.5%, p = 0.046), multivariate analysis failed to show any difference (adjusted p = 0.123). There are 2 potential explanations for this finding. It is possible that ICP monitoring does not have any effect on outcome, as shown by Chesnut et al. 3 The other possible explanation is that the various available pharmacological interventions-for example, heavier sedation and analgesia, pharmacological paralysis, administration of mannitol or hypertonic saline, hyperventilation, or barbiturate coma-are as effective as cerebrospinal fluid drainage.
Another interesting finding was the role of VTE prophylaxis. In both the univariate and multivariate analyses, VTE prophylaxis had a significant protective effect against death. Compliance with the recommendations for VTE prophylaxis in this study was fairly low, with only 56.0% of patients receiving prophylaxis.
This study has the usual limitations of all data bankbased studies. There is significant heterogeneity in the practices of the different hospitals regarding adherence to guidelines and therapeutic interventions, which could influence outcomes and affect the collective results of the study. Lastly, the database does not provide any specific information related to ICP device-related complications. 
